ArTS Archivio della ricerca di Trieste

POZZATO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.247
EU - Europa 10.389
AS - Asia 9.245
SA - Sud America 1.361
Continente sconosciuto - Info sul continente non disponibili 609
AF - Africa 215
OC - Oceania 44
Totale 43.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.908
SG - Singapore 3.359
PL - Polonia 2.100
CN - Cina 2.082
UA - Ucraina 1.586
IT - Italia 1.486
SE - Svezia 1.223
HK - Hong Kong 1.133
BR - Brasile 1.063
VN - Vietnam 894
DE - Germania 782
FI - Finlandia 725
FR - Francia 594
KR - Corea 591
RU - Federazione Russa 419
GB - Regno Unito 391
IE - Irlanda 293
TR - Turchia 285
BG - Bulgaria 281
BD - Bangladesh 270
CA - Canada 170
IN - India 158
NL - Olanda 134
AR - Argentina 102
MX - Messico 90
JP - Giappone 87
CH - Svizzera 66
BE - Belgio 59
PK - Pakistan 59
MA - Marocco 54
ES - Italia 51
IQ - Iraq 50
EC - Ecuador 48
ZA - Sudafrica 41
CO - Colombia 37
AU - Australia 36
PH - Filippine 33
ID - Indonesia 32
SA - Arabia Saudita 32
AT - Austria 31
CL - Cile 30
CZ - Repubblica Ceca 30
EG - Egitto 30
VE - Venezuela 30
RO - Romania 26
IR - Iran 21
PY - Paraguay 19
UZ - Uzbekistan 18
JO - Giordania 17
SN - Senegal 17
KE - Kenya 16
TN - Tunisia 16
CR - Costa Rica 15
EU - Europa 14
TW - Taiwan 14
GR - Grecia 13
IL - Israele 12
PT - Portogallo 12
TH - Thailandia 11
TT - Trinidad e Tobago 11
DZ - Algeria 10
HR - Croazia 10
KZ - Kazakistan 10
PE - Perù 10
UY - Uruguay 10
BO - Bolivia 9
DK - Danimarca 9
LU - Lussemburgo 9
MY - Malesia 9
NO - Norvegia 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
BY - Bielorussia 8
JM - Giamaica 8
LT - Lituania 8
PA - Panama 8
NP - Nepal 7
HN - Honduras 6
HU - Ungheria 6
KG - Kirghizistan 6
OM - Oman 6
RS - Serbia 6
AO - Angola 5
SY - Repubblica araba siriana 5
DO - Repubblica Dominicana 4
GD - Grenada 4
GT - Guatemala 4
LB - Libano 4
NG - Nigeria 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
SV - El Salvador 4
AL - Albania 3
BB - Barbados 3
CI - Costa d'Avorio 3
EE - Estonia 3
GE - Georgia 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
Totale 42.454
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.961
Singapore 1.880
Ann Arbor 1.823
Warsaw 1.816
Ashburn 1.782
Fairfield 1.530
Jacksonville 1.395
Houston 1.391
Chandler 1.253
San Jose 1.203
Hong Kong 1.116
Wilmington 876
Hefei 636
Seoul 579
Seattle 576
Princeton 540
Cambridge 506
Council Bluffs 463
Boardman 433
Beijing 384
Chicago 356
Columbus 349
Trieste 342
Dublin 290
Sofia 277
Munich 257
Zgierz 257
Ho Chi Minh City 248
Lauterbourg 243
Dallas 242
Izmir 242
Helsinki 225
Hanoi 211
Los Angeles 205
Moscow 187
Santa Clara 172
The Dalles 169
Buffalo 149
Milan 146
New York 104
San Diego 104
Düsseldorf 103
Dearborn 102
São Paulo 98
Frankfurt am Main 82
London 71
Phoenix 66
Redwood City 59
Bern 56
Toronto 56
Orem 53
Brussels 51
Guangzhou 47
Shanghai 46
Porto Alegre 45
Haiphong 42
Norwalk 42
Verona 41
Tokyo 40
Tianjin 39
Da Nang 38
Turku 35
Atlanta 34
Rio de Janeiro 34
Rome 34
Brooklyn 32
Casablanca 32
Denver 31
Montreal 31
Redondo Beach 31
Dong Ket 30
Des Moines 29
Kunming 28
Chennai 27
Jinan 27
Sacile 27
Washington 27
Mestre 26
Ottawa 26
San Francisco 26
Nanjing 25
North Bergen 25
Falls Church 24
Stockholm 24
Belo Horizonte 23
Hangzhou 23
Nuremberg 23
Padova 23
Boston 22
Mumbai 22
Baghdad 21
Brasília 21
Duino-Aurisina 21
Grafing 21
Lahore 21
Quito 21
Johannesburg 20
Mexico City 20
Amsterdam 19
Manchester 19
Totale 29.100
Salva come PNG Salva come JPEG
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 498
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 483
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival 479
Potential applications of nanocellulose-containing materials in the biomedical field 474
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 450
Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines 432
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation 415
Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options. 410
Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature 378
Mutations in the 3' untranslated region (3' UTR) of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 348
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 348
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases 339
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 311
The role of the transcription factor E2F1 in hepatocellular carcinoma 311
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 298
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 292
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 289
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 286
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 285
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 278
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 278
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 258
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 257
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 257
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components 256
Translation Elongation 252
A case of burkitt-like B lymphoblastic lymphoma 250
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application. 249
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 249
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 247
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report 247
Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary concentration 246
DEFB1 polymorphisms and salivary hBD-1 concentration in Oral Lichen Planus patients and healthy subjects 245
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia. 244
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism. 242
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 240
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. 230
A transient cutaneous relapse of AML M1 in hematological remission: A case report 228
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway 227
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 225
Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry. 221
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 220
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 216
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 216
Introduction 214
Randomized trial of combination therapy in relapser or non-responder HCV patients 211
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia 206
S-adenosylmethionine counteracts oral contraceptive hepatotoxicity in women 204
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 203
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage. 202
Bortezomib effect of E2F and cyclin family members in human hepatocellular carcinoma cell lines 200
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 200
TP53 mutations with low variant allele frequency predict short survival in Chronic Lymphocytic Leukemia 200
A new genotype: typical of Italy? 197
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles ofTP53disrupted chronic lymphocytic leukaemia cells 195
Abnormality in the hepatic transport of Rifamycin-SV in Gilbert's syndrome 192
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 192
Effects of chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles on a human/mouse model of Burkitt lymphoma 191
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells 191
Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules 189
Improving siRNA Bio-Distribution and Minimizing Side Effects 188
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. 186
A randomized trial comparing different alfa-interferon at different dose and duration as therapy for chronic hepatitis C. 186
Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study 186
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. 184
A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B 183
No evidence of Polyomavirus and EBV infections in Italian patients with mixed cryoglobulinemia infected chronically with HCV 183
A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw. 182
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 182
Merkel-cell polyomavirus and B-cell chronic lymphocytic leukemia 181
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 181
Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands? 180
ALCOHOL HEPATIC TOXICITY IN RAT: EVIDENCE OF THE UTILITY OF THE GASTRIC ETHANOL METABOLISM 179
Acute high-dose ethanol modulates glutathione levels to different degrees in various organs of the rat. 179
Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy 179
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer 179
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 178
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 174
Hematologic problems in the Critically III 173
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells 173
Influence of acid-secretion blockers on gastric and hepatic alcohol dehydrogenase in rat 172
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia. 171
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 170
Abnormal serum gamma-glutamyltranspeptidase in alcoholics: clues to its explanation 170
Cirrhotic thrombocytopenia is a multifactorial condition: evidence of reduced platelet production and incresed platelet destruction 170
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 167
B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinemia syndrome and hepatitis-C virus infection 165
Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. 165
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: relationship to the severity of liver disease and response to the alpha-interferon therapy. 165
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C. 164
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia 164
Gastric and hepatic glutathione after ethanol load: the role of first-pass metabolism and effects of antisecretive drugs. 162
Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials 160
Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. 159
Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas 159
Influence of ascitic fluid characteristics on coagulation disorders after implantation of Le Veen peritoneo-jugular shunt. 159
Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. 157
Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. 156
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 156
"True" histiocytic lymphoma of the stomach associated with colonic cancer and complicated by chronic myeloid leukemica 156
Totale 23.274
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.191
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.416 0 0 151 344 42 156 100 139 367 304 166 647
2022/20233.443 376 378 295 454 374 646 29 263 406 36 125 61
2023/20242.013 165 132 84 98 159 154 296 503 21 63 162 176
2024/20254.890 117 144 308 392 412 464 353 373 824 618 398 487
2025/202611.630 858 691 915 995 1.004 1.208 1.797 401 1.329 1.513 528 391
2026/20271.514 340 652 522 0 0 0 0 0 0 0 0 0
Totale 43.110